Table 1 Cycle characteristics of patients who occurred to oocyte retrieval in the recombinant FSH and the uFSH GnRH antagonist groups.

From: Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study

 

rFSH(608)

uFSH(1298)

p

Embryos transferred

298 (49.01)

714 (55.01)

0.017b

No transferred

310 (50.99)

584 (44.99)

 

The result of ART

Cancelled cycles

297 (48.85)

491 (37.83)

<0.001b

Pregnancy failure

172 (28.29)

493 (37.98)

 

Clinical pregnancy

139 (22.86)

314 (24.19)

 

Live birth

124 (20.39)

253 (19.49)

0.693b

NO live birth

484 (79.61)

1045 (80.51)

 

Number of MII oocytes

10.74 (6.50)

5.49 (3.43)

<0.001a

Number of oocytes fertilized

7.01 (5.00)

3.62 (2.66)

<0.001a

Number of oocytes retrieved

12.24 (7.19)

6.18 (3.81)

<0.001a

LH on day of HCG (mIU/ml)

3.09 (2.60)

3.79 (6.91)

0.001a

Estradiol on day of HCG (pg/ml)

3330.85 (2307.01)

1783.19 (1122.22)

<0.001a

Progesterone on day of HCG (ng/ml)

1.16 (0.64)

0.93 (0.48)

<0.001a

Endometrial thickness (mm)

11.04 (2.51)

10.66 (2.52)

0.002a

Number of follicles on HCG day

10.32 (5.60)

5.82 (3.00)

<0.001a

  1. Data are mean(SD) or number (percentage).
  2. aTwo-sample t-test.
  3. bPearsonχ2 test.
  4. ART: assisted reproductive technology.
  5. MII: metaphase II.
  6. LH: luteinizing hormone.
  7. HCG: human chorionic gonadotropin.